You are here

  • Home
  • Archive
  • Volume 7, Issue 3
  • TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD

Article metrics

Article menu

Download PDFPDF

Infections
Original research
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD

 

Online download statistics by month:

Online download statistics by month: October 2021 to November 2022

AbstractFullPdf
Oct 2021668666119
Nov 2021652650122
Dec 202132331751
Jan 202226125161
Feb 202218018468
Mar 202219618831
Apr 202222422434
May 202221321555
Jun 202218418164
Jul 202213212940
Aug 202213813741
Sep 202217817346
Oct 202214914636
Nov 202212512232
Total36233583800